is her2-low a distinct subtype of breast cancer?
Published 1 year ago • 321 plays • Length 1:36Download video MP4
Download video MP3
Similar videos
-
1:10
the evolution of her2-low-positive breast cancer as a clinical subtype
-
1:40
her2-low is not a distinct subtype in inflammatory breast cancer
-
0:52
defining her2-low breast cancer as a clinical subtype
-
1:05
the genomic characterization of primary and metastatic her2-low breast cancers
-
1:33
questions remaining in the field of her2-low breast cancer
-
2:05
latest news in her2-low breast cancer
-
1:09
the exciting new field of her2-low breast cancer
-
0:31
remaining questions regarding her2-low breast cancer
-
2:14
clinical and molecular characteristics of her2-low/zero early stage triple-negative breast cancer
-
1:17
clinical outcomes in women with metastatic her2-low breast cancer in the real world
-
6:51
adcs for her2 and her2-low breast cancer
-
0:45
the evolution of her2-low breast cancer from primary to recurrence
-
1:25
her2-low as a separate entity for defining her2 bc and its prognostic and biological significance
-
2:21
adcs for the treatment of her2-low breast cancer
-
0:46
biological behaviour of her2-low bc is dependent on hr expression
-
1:26
genomic and transcriptomic landscape of her2-low breast cancer
-
1:45
the comprehensive genomic characterization of her2-low breast cancer
-
2:13
remaining questions surrounding her2-low breast cancer – how low can you go?
-
1:16
her2-low expression in breast cancer